We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cloud Computing Platform Helps Researchers Study Large Quantities of DNA Sequence Data

By LabMedica International staff writers
Posted on 01 Dec 2011
Print article
An open-source, web-based platform for data-intensive biomedical and genetic research, is now available as a “cloud computing” resource.

A team of researchers including Dr. Anton Nekrutenko, an associate professor of biochemistry and molecular biology at Pennsylvania State University (Penn State; University Park, USA); Dr. Kateryna Makova, an associate professor of biology at Penn State; and James Taylor from Emory University (Atlanta, GA, USA), devised the new technology, which will help scientists and biomedical researchers to exploit such tools as DNA-sequencing and analysis software, as well as storage capacity for large quantities of scientific data. Details of the development are to be published as a letter in the journal Nature Biotechnology.

Dr. Nekrutenko reported that he and his team first developed the Galaxy computing system in 2005 because “biology is in a state of shock. Biochemistry and biology labs generate mountains of data, and then scientists wonder, ‘What do we do now? How do we analyze all these data?’” Galaxy, which was developed at Penn State and continues to use the University's servers for its computing power, solves many of the problems that researchers encounter by pulling together a variety of tools that allow for easy retrieval and analysis of large amounts of data, simplifying the process of genomic analysis.

As described in one of the scientists’ early articles in the journal Genome Research, Galaxy, “combines the power of existing genome-annotation databases with a simple Web portal to enable users to search remote resources, combine data from independent queries, and visualize the results.” Galaxy also allows other researchers to be able to review the steps that have been taken, for example, in the analysis of a string of genetic code. “Galaxy offers scientific transparency--the option of creating a public report of analyses. So, after a paper has been published, scientists in other labs can do studies in order to reproduce the results described,” Dr. Nekrutenko said.

Now, the scientists have taken Galaxy to the next phase by developing an “in-the-cloud” option using, for example, the popular Amazon Web Services cloud. “A cloud is basically a network of powerful computers that can be accessed remotely without the need to worry about heating, cooling, and system administration. Such a system allows users, no matter where they are in the world, to shift the workload of software storage, data storage, and hardware infrastructure to this remote location of networked computers,” Dr. Nekrutenko explained. “Rather than run Galaxy on one’s own computer or use Penn State’s servers to access Galaxy, now a researcher can harness the power of the cloud, which allows almost unlimited computing power.”

As a case study, the scientists report on recent research published in Genome Biology in which scientists, with the help of Ian Paul, a professor of pediatrics at Penn State’s Hershey Medical Center, analyzed DNA from nine individuals across three families using Galaxy Cloud. Due to the enormous computing power of the platform, the researchers were able to identify four heteroplasmic sites--variations in mitochondria, the part of the genome passed only from mother to child.

“Galaxy Cloud offers many advantages other than the obvious ones, such as computing power for large amounts of data and the ability for a scientist without much computer training to use DNA-analysis tools that might not otherwise be accessible,” Dr. Nekrutenko concluded. “For example, researchers need not invest in expensive computer infrastructure to be able to perform data-intensive, sophisticated scientific analyses.”

Moreover, another benefit of Galaxy Cloud is its data-storage capacity. Using the Amazon Web Services cloud, researchers have the option of storing vast amounts of data in a secure location. “There are emerging technologies that will produce 100 times more data than existing next-generation DNA sequencing, which already has reached the point where even more storage becomes an issue, not to mention analysis,” Dr. Nekrutenko said.

Related Links:
Pennsylvania State University
Emory University

New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Automated Blood Typing System
IH-500 NEXT
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.